Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers

Michael C. Haffner, Irmgard E. Kronberger, Jeffrey S. Ross, Christine E. Sheehan, Matthias Zitt, Gilbert Mühlmann, Dietmar Öfner, Bettina Zelger, Christian Ensinger, Ximing J. Yang, Stephan Geley, Raimund Margreiter, Neil H. Bander

Research output: Contribution to journalArticle

Abstract

Prostate-specific membrane antigen (PSMA), a type II transmembrane metallo-peptidase highly overexpressed in prostate cancer cells, has been studied as a targeting molecule in prostate cancer. Recently, PSMA has also been found to be expressed in the neovasculature of multiple nonprostatic solid tumors. Because of its unique expression pattern limited to tumor-associated endothelial cells, PSMA may also be an interesting molecule for vascular targeting. In this study, PSMA expression was determined by immunohistochemistry in 119 cases of primary gastric adenocarcinoma, 130 cases of primary colorectal adenocarcinoma, and 24 metastasis of colorectal adenocarcinoma. Expression data were correlated with clinicopathologic information. PSMA expression was detected in tumor-associated neovasculature of 79 (66%) of 119 gastric and 110 (85%) of 130 colorectal carcinomas. Furthermore, the neovasculatures of 16 (84%) of 19 liver and 4 (80%) of 5 nodal metastases from colorectal carcinomas were prostate-specific membrane antigen positive. There was a trend for high-grade tumors to higher PSMA expression (Spearman r = 0.18, P = .046) in colorectal cancers. No association between PSMA expression and overall- or disease-free survival was observed in gastric or colorectal cancers. This study provides the first in-depth look at PSMA expression in gastric and colorectal cancer. Because of its highly tumor-restricted expression and its accessibility to targeted therapy, PSMA represents a promising therapeutic and diagnostic target in colorectal and gastric cancer.

Original languageEnglish (US)
Pages (from-to)1754-1761
Number of pages8
JournalHuman pathology
Volume40
Issue number12
DOIs
StatePublished - Dec 1 2009

Keywords

  • Antiangiogenic therapy
  • Colon cancer
  • FOLH1
  • Gastric cancer
  • Neoangiogenesis
  • PSMA
  • Prognostic factor
  • Tumor endothelial marker
  • Vascular targeting

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint Dive into the research topics of 'Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers'. Together they form a unique fingerprint.

  • Cite this

    Haffner, M. C., Kronberger, I. E., Ross, J. S., Sheehan, C. E., Zitt, M., Mühlmann, G., Öfner, D., Zelger, B., Ensinger, C., Yang, X. J., Geley, S., Margreiter, R., & Bander, N. H. (2009). Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Human pathology, 40(12), 1754-1761. https://doi.org/10.1016/j.humpath.2009.06.003